PLIANT THERAPEUTICS, INC. - 10-Q Filing

Pliant Therapeutics reports third quarter 2026 financial results including updated fair value measurements and equity incentive plan details.

SEC EDGAR ·

Tickers: $PLRX

Read the full article at SEC EDGAR

More Regulatory news